Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target decreased by Bank of America from $61.00 to $47.00 ...
According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price ...
Stock Index Futures Gain With U.S. Presidential Election in Focus, Economic Data and Earnings on Tap
Asian stock markets today settled in the green ... Northern Oil&Gas (NOG), Newmark Group (NMRK), National Health Investors (NHI), Apellis Pharma (APLS), Payoneer Global Inc (PAYO), Consol Energy (CEIX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback